Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
NN, Inc. announced a $50 million net proceeds private investment in public equity (PIPE) financing by issuing 16.1 million shares and pre-funded warrants. The capital will be primarily used to redeem and eliminate Series D Preferred Stock, reducing leverage, and to support business growth through capital expenditures and working capital. The compan…
Applied Digital has completed the second phase of Building 2 at its Polaris Forge 1 campus, adding an additional 75 MW of AI-focused data center infrastructure. This milestone increases the campus's operational critical IT load to 250 MW, reinforcing the company's position in the high-performance computing and AI infrastructure sector. The fully le…
Surrozen, Inc. announced FDA clearance of its Investigational New Drug (IND) application for SZN-8141, a bifunctional Wnt agonist and VEGF antagonist, to treat diabetic macular edema (DME). This milestone enables initiation of the Phase 1b/2a DUET study expected in Q4 2026 and triggers the second closing of a private placement anticipated to raise …
Satellogic Inc. announced the successful launch of its first Merlin satellite along with additional NewSat satellites into low-Earth orbit, marking a significant milestone in deploying its Persistent Global Intelligence infrastructure. The Merlin satellite constellation will provide global detection and theater-scale monitoring with onboard AI proc…
Integra LifeSciences announced a proposed $600 million seven-year Senior Secured Term Loan B as part of a refinancing strategy to refinance existing debt, extend maturities, and maintain financial flexibility. The financing aims to support disciplined capital allocation and deleveraging efforts, subject to market conditions and customary closing re…
Celcuity Inc., a biotechnology firm focused on targeted therapies for solid tumors, has appointed David Gryska to its Board of Directors. Mr. Gryska brings over 35 years of strategic and financial experience in life sciences, including CFO roles and board memberships at multiple biotech companies. This appointment comes as Celcuity transitions into…
NETSOL Technologies, Inc. announced the appointment of Michael Ramsey as Vice President of Sales for its Transcend Finance platform in the Americas. Ramsey brings over 30 years of experience in asset finance enterprise sales and will lead growth initiatives in the U.S., the largest asset finance market globally. This strategic hire aligns with NETS…
Hyperion DeFi, Inc. announced repurchasing over 240,000 shares at a $3.21 average price, fully retiring $8.6 million of legacy debt, and positioning itself for further capital structure optimization. The company aims to leverage its debt-free status and $14.5 million in cash and equivalents to scale its Hyperliquid blockchain ecosystem and DeFi ope…
Teva Pharmaceuticals disclosed new data demonstrating that ecopipam, their investigational treatment for pediatric Tourette syndrome, shows significant tic severity reduction in about 70% of patients within 8 weeks and sustained efficacy with no new safety concerns during long-term follow-up. The drug's efficacy is unaffected by common co-occurring…
Teva Pharmaceuticals announced a comprehensive review published in the Journal of Child Neurology that details the role of dopamine in Tourette syndrome and presents ecopipam, an investigational selective D1 receptor antagonist, as a differentiated and potentially safer treatment for pediatric patients. Data from Phase 2 and 3 trials demonstrate ec…
ServiceNow is executing a profitable pivot: embedding AI across the Now Platform is lifting deal sizes, accelerating revenue growth and improving monetization. The stock still looks like a 'strong buy' for investors willing to accept a premium multiple while AI adoption scales.
Sezzle is trading at $109.73 after a string of product launches and merchant additions that pushed Q2 growth and marketing ROI higher. With revenue growing 51.7% year-over-year, free cash flow of $327.6M and expanding merchant partnerships, the setup favors a mid-term long swing. Entry $109.73, target $145.00, stop $95.00 - horizon 45 trading days.
A scheduled OPEC+ production capacity review that was to establish 2027 output quotas has been postponed to mid-November. The delay follows disruptions to capacity expansion projects across the Middle East stemming from the US-Israeli war on Iran, and several member states have not provided required data, complicating an independent assessment of s…
Boeing's surprise win of the F/A-XX program is a material positive for BA's defense franchise and a short-term shock to competitor Northrop. The award should lift Boeing's backlog, drive near-term defense revenue upside and boost investor confidence in program execution. We recommend a tactical long in BA with a clearly defined stop and target over…
Autodesk's subscription-first business is delivering predictable free cash flow and accelerating AI-driven product value in construction and manufacturing. At $214.20 the market is discounting growth momentum and optionality from generative AI; we recommend a long with a $280 target and a $185.50 stop on a 180-trading-day thesis.
National Energy Services Reunited (NESR) is executing a profitable Middle East expansion driven by the Jafurah ramp-up and a 3B3 growth strategy. With Q2 2026 revenue momentum, improving adjusted EBITDA and a clear $3 billion run-rate target, NESR looks positioned to re-rate from a growth/energy-services multiple. I recommend a long trade with disc…
InflaRx announced its selection for a late-breaking poster session at Kidney Week 2026 to present pre-clinical data on izicopan, an oral C5a receptor antagonist showing therapeutic potential in kidney disease models. Izicopan has demonstrated favorable safety, pharmacokinetics, and efficacy profiles in Phase 1 and 2a studies in inflammatory disease…
Cytokinetics announced four presentations at the 2026 HFSA Annual Scientific Meeting highlighting clinical trial results of aficamten, a cardiac myosin inhibitor for hypertrophic cardiomyopathy (HCM). These presentations include late-breaking data from the ACACIA-HCM and SEQUOIA-HCM trials, emphasizing aficamten's efficacy and safety in non-obstruc…
Aura Minerals announced an agreement to acquire the mining fleet operations currently outsourced to third parties at its Brazilian gold mines Apoena, Almas, and Borborema. This insourcing, planned for January 2027, is expected to reduce all-in sustaining costs by $150-200 per ounce, improve equipment reliability, and provide greater operational con…
Factorial Energy has credible technology that could reshape battery safety and energy density, but commercial traction and consistent manufacturing economics remain unproven. This trade idea outlines a long position sized for high risk / high reward, anchored to a clear entry, stop and target—and a 180 trading day timeline to see pilot-to-scale pro…
An OPEC+ review intended to establish members' sustainable production capacities for setting 2027 quotas has been pushed back after the US-Israeli war on Iran interrupted planned capacity-expansion projects across the Middle East. The review, originally ordered for late 2025 with a completion target by the end of September 2026, has seen its deadli…
Hub Group, Inc. announced major changes to its Board of Directors following a consent action by controlling shareholders, appointing four new directors and removing three without cause. The company also adopted amended bylaws and is actively appealing Nasdaq's decision to initiate delisting due to delayed financial filings. The changes aim to reinf…
RTX is being fed a fresh stream of defense orders — market chatter and company-related reports indicate roughly $45 billion of new awards and multiyear production deals. With a $249 billion market cap, solid free cash flow ($11.4B last reported), and an oversold technical backdrop, this is a tactical long for investors willing to accept program exe…
Rogers Communications partners with Live Nation Canada to present the Backstreet Boys' only 2027 North American stadium shows, offering exclusive presale and premium experiences to Rogers customers. The concert residency celebrates the seminal 'Millennium' album and strengthens Rogers' entertainment portfolio, enhancing customer loyalty and engagem…
Pyxis Oncology, a clinical-stage biopharmaceutical company, has closed a public offering generating approximately $110 million in upfront proceeds, with the potential to raise an additional $172.6 million through exercise of milestone-linked warrants. The funds will support the advancement of its lead drug candidate, micvotabart pelidotin (MICVO), …
